CSL Behring announced that Corifact (factor XIII concentrate [human] injection) has been approved for the routine prophylactic treatment of congenital factor XIII deficiency. Corifact is a ...
Since 1960 when DUCKERT et al., observed a familial bleeding disorder due to a deficiency of Factor XIII, 21 cases, involving 8 families have been reported. We have diagnosed Factor XIII deficiency in ...
Rare clotting factor deficiencies are a collection of bleeding disorders associated with issues with clotting factors. These conditions are inherited and target the proteins in the blood that control ...
Baubui, T., Cartei, G., Chisesi, T., and Dini, E. 1874. Electroimmunoassay of plasma subunits-A and-S in a case of congenital fibrin stabilizing factor deficiency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results